Temsirolimus in the treatment of advanced renal cell carcinoma-Reference-Cited by-同舟云学术

Temsirolimus in the treatment of advanced renal cell carcinoma

Published:2007-07 Issue: Volume:18 Page:ix87-ix88
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Gore M.E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/18/suppl_9/ix87/6673405/mdm299.pdf

Reference12 articles.

1. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma;Motzer;J Clin Oncol,1999

2. Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunotherapie;Negrier;Ann Oncol,2002

3. Do cytokines improve survival in patients with metastatic renal cell carcinoma (MRCC) of intermediate prognosis? Results of the prospective randomized PERCY Quattro trial;Negrier;Proc Am Soc Clin Oncol,2005

4. Cell signaling by receptor tyrosine kinases;Schlessinger;Cell,2000

5. MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor;Yu;J Cell Physiol,1999

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against Candida albicans and Candida auris Biofilms;Journal of Fungi;2023-08-27

2. Temsirolimus Sensitive Stimulation of Platelet Activity, Apoptosis and Aggregation by Collagen Related Peptide;Cellular Physiology and Biochemistry;2017

3. Triggering of Eryptosis, the Suicidal Erythrocyte Death by Mammalian Target of Rapamycin (mTOR) inhibitor Temsirolimus;Cellular Physiology and Biochemistry;2017

4. Interventions for skin reactions associated with targeted anticancer treatments;Cochrane Database of Systematic Reviews;2015-03-27

5. Non-Rash Dermatologic Adverse Events Related to Targeted Therapies;Seminars in Oncology Nursing;2014-08